Trends and Correlates of Breakthrough Infections With SARS-CoV-2.
COVID-19
COVID-19 vaccine
COVID-19 vaccine efficacy
breakthrough infection
delta variant strain
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
17
01
2022
accepted:
04
04
2022
entrez:
27
5
2022
pubmed:
28
5
2022
medline:
31
5
2022
Statut:
epublish
Résumé
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant has been hypothesized to decrease the efficacy of COVID-19 vaccines. Factors associated with infections with SARS-CoV-2 after vaccination are unknown. In this observational cohort study, we examined two groups in Harris County, Texas: (1) individuals with positive Nucleic Acid Amplification test between 12/14/2020 and 9/30/2021 and (2) the subset of individuals fully vaccinated in the same time period. Infected individuals were classified as a breakthrough if their infection occurred 14 days after their vaccination had been completed. Among fully vaccinated individuals, demographic and vaccine factors associated with breakthrough infections were assessed. Of 146,731 positive SARS-CoV-2 tests, 7.5% were breakthrough infections. Correlates of breakthrough infection included young adult age, female, White race, and receiving the Janssen vaccine, after adjustments including the amount of community spread at the time of infection. Vaccines remained effective in decreasing the probability of testing positive for SARS-CoV-2. The data indicate that increased vaccine booster uptake would help decrease new infections.
Identifiants
pubmed: 35619825
doi: 10.3389/fpubh.2022.856532
pmc: PMC9127615
doi:
Substances chimiques
COVID-19 Vaccines
0
Viral Vaccines
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
856532Subventions
Organisme : NIEHS NIH HHS
ID : P30 ES030285
Pays : United States
Informations de copyright
Copyright © 2022 Yamal, Appana, Wang, Leon-Novelo, Bakota, Ye, Sharma, Morrison, Marko, Linder, Rector, Jetelina, Boerwinkle and de Oliveira Otto.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Science. 2021 Dec 17;374(6574):eabl9551
pubmed: 34726481
MMWR Morb Mortal Wkly Rep. 2021 May 28;70(21):792-793
pubmed: 34043615
Am J Pathol. 2022 Feb;192(2):320-331
pubmed: 34774517
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
J Travel Med. 2021 Oct 11;28(7):
pubmed: 34369565
N Engl J Med. 2021 Oct 14;385(16):1474-1484
pubmed: 34320281